-+ 0.00%
-+ 0.00%
-+ 0.00%

Market Chatter: AstraZeneca Said to Axe 600 Jobs from US Respiratory, Immunology Commercial Teams

MT Newswires·11/15/2026 23:05:31
Listen to the news
11:05 PM EST, 11/15/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) slashed 600 positions from its US respiratory and immunology commercial teams as part of its three-year cost-saving program, Bloomberg News reported Nov. 13, citing people familiar with the matter. Some of the employees affected by the cuts were reportedly involved in marketing asthma treatments Airsupra and Breztri. The British drugmaker, which has 25,000 employees in the US, is said to reassign certain staff affected by the changes within the group. AstraZeneca declined to comment when reached by MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)